189 related articles for article (PubMed ID: 11247797)
1. Assembly and activation of HK-PK complex on endothelial cells results in bradykinin liberation and NO formation.
Zhao Y; Qiu Q; Mahdi F; Shariat-Madar Z; Røjkjaer R; Schmaier AH
Am J Physiol Heart Circ Physiol; 2001 Apr; 280(4):H1821-9. PubMed ID: 11247797
[TBL] [Abstract][Full Text] [Related]
2. The relative priority of prekallikrein and factors XI/XIa assembly on cultured endothelial cells.
Mahdi F; Shariat-Madar Z; Schmaier AH
J Biol Chem; 2003 Nov; 278(45):43983-90. PubMed ID: 12944405
[TBL] [Abstract][Full Text] [Related]
3. Activation of the bradykinin-forming cascade on endothelial cells: a role for heat shock protein 90.
Joseph K; Tholanikunnel BG; Kaplan AP
Int Immunopharmacol; 2002 Dec; 2(13-14):1851-9. PubMed ID: 12489799
[TBL] [Abstract][Full Text] [Related]
4. Pathogenic mechanisms of bradykinin mediated diseases: dysregulation of an innate inflammatory pathway.
Kaplan AP; Joseph K
Adv Immunol; 2014; 121():41-89. PubMed ID: 24388213
[TBL] [Abstract][Full Text] [Related]
5. Assembly of high molecular weight kininogen and activation of prekallikrein on cell matrix.
Motta G; Shariat-Madar Z; Mahdi F; Sampaio CA; Schmaier AH
Thromb Haemost; 2001 Sep; 86(3):840-7. PubMed ID: 11583317
[TBL] [Abstract][Full Text] [Related]
6. The carboxyl terminus of bradykinin and amino terminus of the light chain of kininogens comprise an endothelial cell binding domain.
Hasan AA; Cines DB; Zhang J; Schmaier AH
J Biol Chem; 1994 Dec; 269(50):31822-30. PubMed ID: 7989355
[TBL] [Abstract][Full Text] [Related]
7. Generation of vasoactive peptide bradykinin from human umbilical vein endothelium-bound high molecular weight kininogen by plasma kallikrein.
Nishikawa K; Shibayama Y; Kuna P; Calcaterra E; Kaplan AP; Reddigari SR
Blood; 1992 Oct; 80(8):1980-8. PubMed ID: 1391955
[TBL] [Abstract][Full Text] [Related]
8. High molecular weight kininogen and factor XII binding to endothelial cells and astrocytes.
Fernando LP; Natesan S; Joseph K; Kaplan AP
Thromb Haemost; 2003 Nov; 90(5):787-95. PubMed ID: 14597972
[TBL] [Abstract][Full Text] [Related]
9. Factor XII-independent activation of the bradykinin-forming cascade: Implications for the pathogenesis of hereditary angioedema types I and II.
Joseph K; Tholanikunnel BG; Bygum A; Ghebrehiwet B; Kaplan AP
J Allergy Clin Immunol; 2013 Aug; 132(2):470-5. PubMed ID: 23672780
[TBL] [Abstract][Full Text] [Related]
10. Factor XI, but not prekallikrein, blocks high molecular weight kininogen binding to human umbilical vein endothelial cells.
Baird TR; Walsh PN
J Biol Chem; 2003 Jun; 278(23):20618-23. PubMed ID: 12663668
[TBL] [Abstract][Full Text] [Related]
11. Factor XII-independent cleavage of high-molecular-weight kininogen by prekallikrein and inhibition by C1 inhibitor.
Joseph K; Tholanikunnel BG; Kaplan AP
J Allergy Clin Immunol; 2009 Jul; 124(1):143-9. PubMed ID: 19342086
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of contact activation by a kininogen peptide (HKH20) derived from domain 5.
Nakazawa Y; Joseph K; Kaplan AP
Int Immunopharmacol; 2002 Dec; 2(13-14):1875-85. PubMed ID: 12494915
[TBL] [Abstract][Full Text] [Related]
13. Assessment of the role of heparan sulfate in high molecular weight kininogen binding to human umbilical vein endothelial cells.
Fernando LP; Fernando AN; Joseph K; Kaplan AP
J Thromb Haemost; 2003 Nov; 1(11):2444-9. PubMed ID: 14629481
[TBL] [Abstract][Full Text] [Related]
14. The bradykinin-forming cascade: a historical perspective.
Kaplan AP
Chem Immunol Allergy; 2014; 100():205-13. PubMed ID: 24925400
[TBL] [Abstract][Full Text] [Related]
15. Human Hageman factor (factor XII) and high molecular weight kininogen compete for the same binding site on human umbilical vein endothelial cells.
Reddigari SR; Shibayama Y; Brunnée T; Kaplan AP
J Biol Chem; 1993 Jun; 268(16):11982-7. PubMed ID: 8505323
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of prolylcarboxypeptidase as an endothelial cell prekallikrein activator.
Shariat-Madar Z; Mahdi F; Schmaier AH
J Biol Chem; 2002 May; 277(20):17962-9. PubMed ID: 11830581
[TBL] [Abstract][Full Text] [Related]
17. Endothelial cell permeability during hantavirus infection involves factor XII-dependent increased activation of the kallikrein-kinin system.
Taylor SL; Wahl-Jensen V; Copeland AM; Jahrling PB; Schmaljohn CS
PLoS Pathog; 2013; 9(7):e1003470. PubMed ID: 23874198
[TBL] [Abstract][Full Text] [Related]
18. Bradykinin regulates the expression of kininogen binding sites on endothelial cells.
Zini JM; Schmaier AH; Cines DB
Blood; 1993 Jun; 81(11):2936-46. PubMed ID: 8388750
[TBL] [Abstract][Full Text] [Related]
19. Identification of prolylcarboxypeptidase as the cell matrix-associated prekallikrein activator.
Moreira CR; Schmaier AH; Mahdi F; da Motta G; Nader HB; Shariat-Madar Z
FEBS Lett; 2002 Jul; 523(1-3):167-70. PubMed ID: 12123826
[TBL] [Abstract][Full Text] [Related]
20. High-molecular-weight kininogen is exclusively membrane bound on endothelial cells to influence activation of vascular endothelium.
Hasan AA; Cines DB; Ngaiza JR; Jaffe EA; Schmaier AH
Blood; 1995 Jun; 85(11):3134-43. PubMed ID: 7756645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
